Provenir Achieves Significant Revenue and Customer Growth in 2022; Expands Global Market Leadership in Data and AI-Powered Risk Decisioning for Financial Services
The company adds new customers around the globe and grows its employee count as it…
The company adds new customers around the globe and grows its employee count as it…
NEW YORK & MUMBAI, India–(BUSINESS WIRE)–$WNS #AshishJhajharia–WNS (Holdings) Limited (NYSE: WNS), a leading provider of…
– Wednesday, February 15th, 2023 12:00 EST – Virtual Fireside Chat via Paltalk Platform BOSTON,…
The Company will Acquire Back 10% of Issued and Outstanding Shares of its Non-Wholly Owned Subsidiary and…
SAN DIEGO, Calif., and SUZHOU, China and SHANGHAI, China, Feb. 14, 2023 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc. (“Gracell” or the…
Bylvay (odevixibat) granted Priority Review by U.S. FDA ASSERT study demonstrated efficacy of Bylvay in…
Dr. Adi Zuloff-Shani PhD., Clearmind’s chief executive officer will discuss its Nasdaq IPO with David…
– Second quarter total revenue and government support income increased over 100% year-over-year – –…
Pre-launch commercial activities underway as Company advances toward U.S. Food and Drug Administration (FDA) Prescription…
Study shows increases in learning consumption across Skillsoft portfolio; highlights in-demand skills and top trends…
Funding matches Alabama Research and Development Enhancement Fund (ARDEF) grant to Kyounga Cheon, D.M.D., M.S.,…
WALTHAM, Mass., Feb. 14, 2023 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing…
BUFFALO, N.Y., Feb. 14, 2023 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
Seasoned veteran in vascular space adds significant expertise in U.S. commercial market readiness and global…
OLINVYK demonstrated a reduced impact on respiratory depression compared to IV morphine, among elderly/overweight subjects…
NRTX-1001 administration is well-tolerated and shows seizure reduction of >90% in the first two patients…
SAN DIEGO, Feb. 14, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology…
Proposed listing on NASDAQ with RADX ticker symbol Form 20-F registration filed with Securities and…
Intense interest in PharmAla’s best-in-class manufacturing and regulatory excellence continues as PharmAla examines further Australian…
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…